SPL Chemicals: Specialty
Process Industries
50.89 +10.01%
Mkt Cap
2.5B
P/E (TTM)
17.44
EPS (TTM)
2.65
ROE (TTM)
13.00%
Div Yield
—
Sitara Peroxide Limited (SPL) Financial Statements, Ratios & Dividends
About
Sitara Peroxide Ltd. engages in the business of manufacturing and sale of hydrogen peroxide and Sitara safe disinfectant. Its products include Sitara safe and hydrogen peroxide H202 in jerry can and IBC. The company was founded in 1981 and is headquartered in Faisalabad, Pakistan.
Financial Highlights
| FY2025 | FY2024 | ||
|---|---|---|---|
| Revenue | 0 | 14.90M | |
| Gross Profit | -180.26M | -202.78M | |
| Net Income | -222.52M | -169.35M | |
| EPS | -4.04 | -3.07 | |
| ROE | -20.22% | -13.37% | |
| ROA | -7.05% | -5.04% | |
| Gross Margin | — | -1360.90% | |
| Net Margin | — | -1136.53% | |
| Current Ratio | 0.28 | 0.35 | |
| DPS | 0.00 | 0.00 | |
| Free Cash Flow | 19.65M | -5.11M |
| FY2025 | FY2024 | ||
|---|---|---|---|
| Total Revenue | 0 | 14.90M | |
| Cost of Goods Sold | -180.26M | -217.68M | |
| Gross Profit | -180.26M | -202.78M | |
| SG&A Expenses | -139.26M | -167.33M | |
| Depreciation | -180.26M | -183.82M | |
| Other Operating Expense | 0 | -198.3K | |
| Total Operating Expense | -319.52M | -385.22M | |
| Operating Income (EBIT) | -319.52M | -370.32M | |
| Interest Income | 0 | 34.8K | |
| Interest Expense | -4.74M | -24.95M | |
| Equity in Earnings | 0 | 0 | |
| Other Non-Operating Income | 0 | 89.52M | |
| Total Non-Operating Income | 8.16M | 64.61M | |
| Pre-Tax Income | -311.35M | -305.71M | |
| Income Tax | 88.84M | 136.36M | |
| Minority Interest | 0 | 0 | |
| Net Income | -222.52M | -169.35M | |
| EBITDA | -139.26M | -186.50M | |
| EPS (Basic) | -4.04 | -3.07 | |
| EPS (Diluted) | -4.04 | -3.07 | |
| Gross Margin | — | -1360.90% | |
| Operating Margin | — | -2485.23% | |
| EBITDA Margin | — | -1251.60% | |
| Pre-Tax Margin | — | -2051.65% | |
| Net Margin | — | -1136.53% |
| FY2025 | FY2024 | ||
|---|---|---|---|
| Profitability | |||
| Return on Equity (ROE) | -20.22% | -13.37% | |
| Return on Assets (ROA) | -7.05% | -5.04% | |
| Return on Invested Capital | -20.22% | -13.37% | |
| Gross Margin | — | -1360.90% | |
| Operating Margin | — | -2485.23% | |
| EBITDA Margin | — | -1251.60% | |
| Net Margin | — | -1136.53% | |
| Pre-Tax Margin | — | -2051.65% | |
| Liquidity | |||
| Current Ratio | 0.28 | 0.35 | |
| Quick Ratio | 0.06 | 0.13 | |
| Leverage | |||
| Debt / Equity | 0.10 | 0.10 | |
| Debt / Assets | 0.03 | 0.04 | |
| LT Debt / Equity | 0.00 | 0.00 | |
| LT Debt / Assets | 0.00 | 0.00 | |
| Net Debt | 96.08M | 115.36M | |
| Total Debt | 101.74M | 126.74M | |
| Efficiency | |||
| Asset Turnover | 0.00 | 0.00 | |
| Inventory Turnover | 0.53 | 0.63 | |
| Per Share | |||
| Book Value Per Share | 17.95 | 21.99 | |
| Tangible Book Per Share | 17.95 | 21.99 | |
| Cash Per Share | 0.10 | 0.21 | |
| Total Debt Per Share | 1.85 | 2.30 | |
| Working Capital Per Share | -20.05 | -17.68 | |
| Shares & Market | |||
| Total Shares Outstanding | 55,100,000 | 55,100,000 | |
| Market Cap | 820.44M | 730.08M | |
| Enterprise Value | 916.52M | 845.43M | |
| Employees | 13 | 15 | |
| Shareholders | 6,215 | 6,215 | |
| FY2025 | FY2024 | ||
|---|---|---|---|
| Dividends Per Share | 0.00 | 0.00 | |
| Dividend Yield | 0.00% | 0.00% | |
| Total Dividends Paid | 0 | 0 |
| FY2025 | FY2024 | ||
|---|---|---|---|
| P/B Ratio | 0.83 | 0.60 | |
| P/S Ratio | — | 49.00 | |
| P/CF Ratio | 41.75 | — | |
| Market Cap | 820.44M | 730.08M | |
| Enterprise Value | 916.52M | 845.43M |
| TTM | ||
|---|---|---|
| Income | ||
| Revenue | 0 | |
| Gross Profit | -177.11M | |
| Operating Income | -236.27M | |
| Net Income | 146.14M | |
| EBIT | -236.27M | |
| Free Cash Flow | -50.90M | |
| EPS (Basic) | 2.65 | |
| Margins | ||
| Returns | ||
| Return on Equity (ROE) | 13.00% | |
| ROIC | 0.13% | |
| Coverage & Debt | ||
| Interest Coverage | -5.9x | |
| Valuation & Scores | ||
| P/E (TTM) | 17.44 | |
| Sloan Ratio | 1.51 | |
| Zmijewski Score | -1.49 | |
Computed Metrics (Latest Period)
| FY2025 | ||
|---|---|---|
| Extended Returns | ||
| Return on Common Equity | -20.22% | |
| Return on Tangible Equity | -20.22% | |
| Return on Tangible Assets | -7.05% | |
| Return on Total Capital | -26.31% | |
| ROCE | -19.55% | |
| Growth | ||
| EPS Diluted Growth | -0.31% | |
| Quality & Risk Scores | ||
| Piotroski F-Score | 4 | |
| Zmijewski Score | -0.18 | |
| Sloan Ratio | -7.99 | |
| Valuation (Computed) | ||
| Tobin's Q Ratio | 0.27 | |
| Leverage & Coverage | ||
| Interest Coverage | -67.5x | |
| Total Debt / Capital | 0.09% | |
| Assets / Equity (Leverage) | 3.07 | |
| Effective Interest Rate | 4.15% | |
| Efficiency (Computed) | ||
| Fixed Asset Turnover | 0.00 | |
| Receivables Turnover | 0.00 | |
| Dividends (Computed) | ||
| Share Buyback Ratio | 0.00 | |
| Per Employee | ||
| Revenue / Employee | 0 | |
| Net Income / Employee | -17.12M | |
| Oper. Income / Employee | -24.58M | |
| Total Assets / Employee | 233.20M | |
| Balance Sheet (Computed) | ||
| Tangible Assets | 3.03B | |
| Invested Capital | 989.06M | |
| Working Capital | -1.10B | |
| Book Value Per Share | 17.95 | |
| Earnings Schedule | ||
| Next Earnings Date | 3 Mar 2027 | |